As a result of the news that has circulated about the study of a possible case of monkeypox in Colombia, The National Institute of Health (INS) announced today that although the ‘probable case’ was followed up, the contact review has been cancelled.
(Keep reading: WHO anticipates more cases of monkeypox will appear)
This is because “yesterday afternoon it was determined that when the ‘probable’ case was in the country, he was not infected. In such a way that it was already discarded”clarified the entity.
(Besides: Monkeypox and human smallpox: these are the similarities and differences)
In this regard, Martha Ospina, Director of the National Institute of Health (INS), told EL TIEMPO yesterday that “In Colombia we have not studied any case. A man came from Spain and visited some cities here and when he returned to his country he presented a characteristic clinical picture, They did his tests and he was confirmed.”
(Of your interest: US Deploys Monkeypox Vaccines to Susceptible Population)
According to what has been reported by the National Institute of Health (INS) There are still no confirmed cases of monkeypox in Colombia.
The country continues to work on the study and follow-up of any case that meets the profile that has already been defined in the guidelines given to entities that provide health services.
Given the rumors generated in public opinion, the INS says that despite not having a diagnosis in the country, its obligation is to follow up. However, it has already been determined that this ‘probable case’ was not infected when he visited Colombia.
In addition, the entity emphasizes that all the cases presented in the world and in the places where the outbreaks have originated, present benign, self-limited conditions (that is, the disease completes its period of time and the individual begins its recovery) and without complications.
According to the INS, early detection is very important to break a chain of transmission. When the virus reaches organs of the human body such as the brain or lungs it can cause death, but death is more likely to occur in a thousand cases than in a few cases.
In Colombia, the work focuses on fine-tuning the Public Health Surveillance System.
The INS has reinforced monitoring of diseases or outbreaks that cause rashes or skin eruptions.
(Also read: Monkeypox: how it is transmitted, symptoms and population at risk )
In addition, the entity also carried out an analysis of the situation with the United States Centers for Disease Control and Prevention (CDC) and they are building a surveillance guideline for health services.
More health news
–EMA reviews available treatments and vaccines for monkeypox
-These are the views of a priest on sexuality and religion